首頁
Minapharm Pharmaceuticals

3月 2026Minapharm Pharmaceuticals的市場佔有率分析

minapharm is a leading pharmaceutical company in egypt & the middle east & the premier biopharmaceutical company in africa with +20 years of experience in cellular & bioprocess engineering.

健康 > 藥房

域名minapharm.com

成立年份1958

僱員1001 - 5000

年度營收$500M - $1B

Minapharm Pharmaceuticals

Minapharm Pharmaceuticals（包含公司地區）

minapharm.com

查看更多網站流量與參與度資訊

Minapharm Pharmaceuticals截至 3月 2026 的總收入為 500M - 1B

Minapharm Pharmaceuticals 熱門網域產生的總收入

Minapharm Pharmaceuticals 熱門網域 3 年內的總收入

Minapharm Pharmaceuticals 熱門網域的總收入

minapharm.com500M - 1B

透過銷售情報查看更多內容

Minapharm Pharmaceuticals的熱門網域總造訪量

了解Minapharm Pharmaceuticals市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

minapharm.com4.1K

透過銷售情報查看更多內容

Minapharm Pharmaceuticals的熱門網域平均造訪時長

分析Minapharm Pharmaceuticals參與度指標。

過去 3 個月平均造訪時長

子公司細目

minapharm.com00:01:31

透過銷售情報查看更多內容

Minapharm Pharmaceuticals的熱門網域平均頁面瀏覽量

了解Minapharm Pharmaceuticals如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

minapharm.com2.47

透過銷售情報查看更多內容

Minapharm Pharmaceuticals按網域劃分的熱門競爭對手

3月 2026的熱門類似網站，依相似度排名

imexpharm.com公司名Imexpharm Corporation僱員1001 - 5000總部越南, Cao Lanh年度營收$50M - $75M訪問總量9.1K健康 > 健康 - 其他

使用的熱門技術Minapharm Pharmaceuticals

这些是Minapharm Pharmaceuticals顶级域名使用的行业网站技术

付費廣告 (7)

DoubleClick

內容管理系統 (4)

WordPress

轉換與分析 (4)

Google Analytics

付款與貨幣 (3)

Euro

更多技術

7

檢視所有

新聞與訊號來自Minapharm Pharmaceuticals

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞African Development Bank invests into Minapharm $17.1M in senior corporate loan.EGYPT - The African Development Bank (AfDB) has approved a €15 million senior corporate loan to Minapharm Pharmaceuticals S.A.E., a leading Egyptian biopharmaceutical company, to support its ambitious expansion and renovation plans.

新聞Minapharm is developing modern immunotherapies for Egypt.Minapharm continues to venture into the future of biotech by investing in two new facilities in Cairo and Berlin, enabling synergy projects to jointly develop modern immunotherapies for Egypt, the MENA region and beyond.

新聞Minapharm is developing modern immunotherapies for Egypt.“The establishment of a hybrid bioengineering R&D community of Egyptian and German scientists allows us to constantly innovate, with synergistic projects driving technology transfer between Cairo and Minapharm continues to venture into the future of biotech by investing in new facilities in Egypt and Berlin, opening the door for synergy projects to jointly develop and produce modern immunotherapies for Egypt, the MENA region and beyond.